Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lees

Showing results (521-530 of 1,055) with videos related to

Pageof 106
Sort By:
Expert Review of Neurotherapeutics|June 6, 2017
Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPAAndrew J Lees, Joaquim Ferreira, Olivier Rascol, et al.
Brain Research|July 16, 2008
Age-related neuroanatomical differences from the juvenile period to adulthood in mother-reared macaques (Macaca radiata)Peter J Pierre, William D Hopkins, Jarred P Taglialatela, et al.
Current Medicinal Chemistry|August 27, 2010
Insights into the molecular mechanism of hERG1 channel activation and blockade by drugsS Durdagi, J Subbotina, J Lees-Miller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 16, 2010
Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviorsCharlotte R Housden, Sean S O'Sullivan, Eileen M Joyce, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2000
An ambulatory dyskinesia monitorA J Manson, P Brown, J D O'Sullivan, et al.
Physics in Medicine and Biology|October 1, 1995
Diffusion in Fe(II/III) radiation dosimetry gels measured by magnetic resonance imagingB J Balcom, T J Lees, A R Sharp, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's diseaseK Sieradzan, S Channon, C Ramponi, et al.
Annals of Neurology|September 4, 2003
The role of pathogenic DJ-1 mutations in Parkinson's diseasePatrick M Abou-Sleiman, Daniel G Healy, Niall Quinn, et al.
The Journal of Organic Chemistry|January 18, 2003
Tuning the optical properties of fluorinated indolylfulgimidesMason A Wolak, Craig J Thomas, Nathan B Gillespie, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|August 9, 2002
Support of daily ECG procedures in a cardiology department via the integration of an existing clinical database and a commercial ECG management systemFranco Chiarugi, David Lombardi, Philip J Lees, et al.
Pageof 106

Showing results (521-530 of 1,055) with videos related to

Sort By:
Pageof 106
Expert Review of Neurotherapeutics|June 6, 2017
Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPAAndrew J Lees, Joaquim Ferreira, Olivier Rascol, et al.
Brain Research|July 16, 2008
Age-related neuroanatomical differences from the juvenile period to adulthood in mother-reared macaques (Macaca radiata)Peter J Pierre, William D Hopkins, Jarred P Taglialatela, et al.
Current Medicinal Chemistry|August 27, 2010
Insights into the molecular mechanism of hERG1 channel activation and blockade by drugsS Durdagi, J Subbotina, J Lees-Miller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 16, 2010
Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviorsCharlotte R Housden, Sean S O'Sullivan, Eileen M Joyce, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2000
An ambulatory dyskinesia monitorA J Manson, P Brown, J D O'Sullivan, et al.
Physics in Medicine and Biology|October 1, 1995
Diffusion in Fe(II/III) radiation dosimetry gels measured by magnetic resonance imagingB J Balcom, T J Lees, A R Sharp, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
The therapeutic potential of moclobemide, a reversible selective monoamine oxidase A inhibitor in Parkinson's diseaseK Sieradzan, S Channon, C Ramponi, et al.
Annals of Neurology|September 4, 2003
The role of pathogenic DJ-1 mutations in Parkinson's diseasePatrick M Abou-Sleiman, Daniel G Healy, Niall Quinn, et al.
The Journal of Organic Chemistry|January 18, 2003
Tuning the optical properties of fluorinated indolylfulgimidesMason A Wolak, Craig J Thomas, Nathan B Gillespie, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|August 9, 2002
Support of daily ECG procedures in a cardiology department via the integration of an existing clinical database and a commercial ECG management systemFranco Chiarugi, David Lombardi, Philip J Lees, et al.
Pageof 106